Paradigm Partner Completes FDA Submission for Retimax

Paradigm Medical Industries, Inc. announced that it has been notified by its Italian partner, Costruzione Strumenti Oftalmici, that all necessary documents have been completed and submitted to the United States Food and Drug Administration (FDA) for the Retimax, also known as the Paramax.
CNNMoney